(VIANEWS) – Matador Resources Company (MTDR), M/I Homes (MHO), QCR Holdings (QCRH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Matador Resources Company (MTDR)
28.6% sales growth and 23.96% return on equity
Matador Resources Company, an independent energy company, engages in the exploration, development, production, and acquisition of oil and natural gas resources in the United States. It operates through two segments, Exploration and Production; and Midstream. The company primarily holds interests in the Wolfcamp and Bone Spring plays in the Delaware Basin in Southeast New Mexico and West Texas. It also operates the Eagle Ford shale play in South Texas; and the Haynesville shale and Cotton Valley plays in Northwest Louisiana. In addition, the company conducts midstream operations in support of its exploration, development, and production operations. Further, it provides natural gas processing and oil transportation services; and oil, natural gas, and produced water gathering services, as well as produced water disposal services to third parties. The company was formerly known as Matador Holdco, Inc. and changed its name to Matador Resources Company in August 2011. Matador Resources Company was founded in 2003 and is headquartered in Dallas, Texas.
Earnings Per Share
As for profitability, Matador Resources Company has a trailing twelve months EPS of $7.77.
PE Ratio
Matador Resources Company has a trailing twelve months price to earnings ratio of 7.48. Meaning, the purchaser of the share is investing $7.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.96%.
2. M/I Homes (MHO)
17.5% sales growth and 21% return on equity
M/I Homes, Inc., together with its subsidiaries, operates as a builder of single-family homes in Ohio, Indiana, Illinois, Minnesota, Michigan, Florida, Texas, North Carolina, and Tennessee. The company operates through Northern Homebuilding, Southern Homebuilding, and Financial Services segments. It also designs, constructs, markets, and sells single-family homes and attached townhomes to first-time, millennial, move-up, empty-nester, and luxury buyers under the M/I Homes brand name. In addition, the company purchases undeveloped land to develop into developed lots for the construction of single-family homes, as well as for sale to others. Further, it originates and sells mortgages; and serves as a title insurance agent by providing title insurance policies, examination, and closing services to purchasers of its homes. M/I Homes, Inc. was founded in 1976 and is based in Columbus, Ohio.
Earnings Per Share
As for profitability, M/I Homes has a trailing twelve months EPS of $18.33.
PE Ratio
M/I Homes has a trailing twelve months price to earnings ratio of 8.98. Meaning, the purchaser of the share is investing $8.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21%.
Sales Growth
M/I Homes’s sales growth is 5.6% for the current quarter and 17.5% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 0.8% and 31.7%, respectively.
Previous days news about M/I Homes(MHO)
- M/i homes (mho) stock sinks as market gains: here's why. According to Zacks on Tuesday, 10 September, "The investment community will be paying close attention to the earnings performance of M/I Homes in its upcoming release. ", "On that day, M/I Homes is projected to report earnings of $4.94 per share, which would represent year-over-year growth of 2.49%. "
3. QCR Holdings (QCRH)
12.7% sales growth and 12.94% return on equity
QCR Holdings, Inc., a multi-bank holding company, provides commercial and consumer banking, and trust and asset management services. Its deposit products include noninterest-bearing demand, interest-bearing demand, time, and brokered deposits. The company also provides various commercial and retail lending/leasing, and investment services to corporations, partnerships, individuals, and government agencies. Its loan portfolio comprises loans to small and mid-sized businesses; business loans, including lines of credit for working capital and operational purposes; term loans for the acquisition of facilities, equipment, and other purposes; commercial and residential real estate loans; and installment and other consumer loans, such as home improvement, home equity, motor vehicle, and signature loans, as well as small personal credit lines. In addition, the company engages in leasing of machinery and equipment to commercial and industrial businesses under direct financing lease contracts; and issuance of trust preferred securities. It serves the Quad Cities, Cedar Rapids, Cedar Valley, Des Moines/Ankeny, and Springfield communities. The company was founded in 1993 and is headquartered in Moline, Illinois.
Earnings Per Share
As for profitability, QCR Holdings has a trailing twelve months EPS of $6.74.
PE Ratio
QCR Holdings has a trailing twelve months price to earnings ratio of 11.44. Meaning, the purchaser of the share is investing $11.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.94%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 0.7% and a drop 20.8% for the next.
4. Amphastar Pharmaceuticals (AMPH)
10.5% sales growth and 25.57% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $3.15.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 15.51. Meaning, the purchaser of the share is investing $15.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.57%.
Yearly Top and Bottom Value
Amphastar Pharmaceuticals’s stock is valued at $48.86 at 01:22 EST, way under its 52-week high of $65.92 and way above its 52-week low of $36.56.
Moving Average
Amphastar Pharmaceuticals’s value is way higher than its 50-day moving average of $41.73 and higher than its 200-day moving average of $47.47.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.2%, now sitting on 712.89M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 12.2% and positive 12.5% for the next.
5. Huron Consulting Group (HURN)
10.2% sales growth and 15.17% return on equity
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; financial advisory; software products; and digital solutions, spanning technology and analytic-related services to national and regional health systems, academic and community health systems, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment provides research enterprise, and student and alumni lifecycle; digital solutions, spanning technology, and analytic-related services; Huron Research Suite, a software suite designed to facilitate and enhance research administration service delivery and compliance; and organizational transformation services to public and private colleges and universities, research institutes, and other education-related organizations. The Commercial segment delivers digital services and software products, and financial advisory services to financial, energy and utilities, professional and business services, life science, consumer products, and industrials and manufacturing industries, as well as public sector and nonprofit organizations. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, Huron Consulting Group has a trailing twelve months EPS of $4.2.
PE Ratio
Huron Consulting Group has a trailing twelve months price to earnings ratio of 26.3. Meaning, the purchaser of the share is investing $26.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.17%.
Volume
Today’s last reported volume for Huron Consulting Group is 116114 which is 25.87% below its average volume of 156646.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.2%, now sitting on 1.43B for the twelve trailing months.
Yearly Top and Bottom Value
Huron Consulting Group’s stock is valued at $110.44 at 01:22 EST, under its 52-week high of $115.65 and way higher than its 52-week low of $84.26.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 15.8% and 15.5%, respectively.
6. Cooper Companies (COO)
9.6% sales growth and 4.65% return on equity
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Earnings Per Share
As for profitability, Cooper Companies has a trailing twelve months EPS of $1.46.
PE Ratio
Cooper Companies has a trailing twelve months price to earnings ratio of 64.05. Meaning, the purchaser of the share is investing $64.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.65%.
Moving Average
Cooper Companies’s worth is higher than its 50-day moving average of $92.98 and under its 200-day moving average of $93.59.
Previous days news about Cooper Companies(COO)
- According to Zacks on Tuesday, 10 September, "(ACGL Quick QuoteACGL – Free Report) , The Cooper Companies Inc. (COO Quick QuoteCOO – Free Report) , Erie Indemnity Co. (ERIE Quick QuoteERIE – Free Report) and Workday Inc. (WDAY Quick QuoteWDAY – Free Report) . "
7. First Business Financial Services (FBIZ)
7.8% sales growth and 13.5% return on equity
First Business Financial Services, Inc. operates as the bank holding company for First Business Bank that provides commercial banking products and services for small and medium-sized businesses, business owners, executives, professionals, and high net worth individuals in Wisconsin, Kansas, and Missouri. The company offers real estate lending, commercial and industrial lending, asset-based lending, accounts receivable financing, equipment financing loans and leases, floorplan financing, vendor financing, small business administration lending and servicing, treasury management solutions, and company retirement services. It also provides private wealth management for individuals, including creating and executing asset allocation strategies, trust and estate administration, financial planning, investment management, and access to brokerage and custody-only services. In addition, the company offers bank consulting consisting of investment portfolio administrative and asset liability management services, and commercial deposit accounts. The company was founded in 1909 and is headquartered in Madison, Wisconsin.
Earnings Per Share
As for profitability, First Business Financial Services has a trailing twelve months EPS of $4.57.
PE Ratio
First Business Financial Services has a trailing twelve months price to earnings ratio of 9.93. Meaning, the purchaser of the share is investing $9.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.5%.
Yearly Top and Bottom Value
First Business Financial Services’s stock is valued at $45.37 at 01:22 EST, under its 52-week high of $47.23 and way above its 52-week low of $28.36.
Moving Average
First Business Financial Services’s worth is way above its 50-day moving average of $40.66 and way above its 200-day moving average of $36.76.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Aug 8, 2024, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 2.22%.
Volume
Today’s last reported volume for First Business Financial Services is 6655 which is 59.61% below its average volume of 16479.
